GlassScriptPhysician profile
Michael J Cisar
NPI 1831269372
$862.35
in general payments reported to CMS, 2019-2025
9 companies · $297 in 2025
The $297 reported for 2025 was more than what 83% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.58 · 2021: $50.00 · 2022: $313 · 2023: $82.95 · 2024: $50.00 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $257 · Education: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.64 |
| Education | $173.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $244.19 | 2022-2025 | |
| Envista Holdings Corporation | $226.73 | 2025 | Optibond Solo Plus, I-Cat Flxflx Mv, Zirconia Abutment Preparation Kit |
| 3m Company | $179.08 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $50.00 | 2021 | |
| Kerr Corporation | $41.48 | 2023 | Harmonize, Zirconia Abutment Preparation Kit |
| Nobel Biocare USA | $41.47 | 2023 | Nobelactive |
| Orapharma, A Division of Bausch Health US, LLC | $40.81 | 2019-2025 | Ossix Plus, Arestin |
| Geistlich Pharma, North America, INC. | $26.72 | 2019 | |
| Dentsply Sirona INC | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cisar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.